The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
The summary for the The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed): This Notice of Funding Opportunity (NOFO) invites applications to serve as the National Institute of Neurological Disorders and Stroke (NINDS) Human Biospecimen and Data Repository in Neurological Disorders. This repository will maintain the current collection of biospecimens as well as support expansion of the collection in accordance with the NINDS mission. The NINDS Human Biospecimen and Data Repository will distribute biospecimens broadly to qualified academic and industry researchers to advance basic, translational and clinical research in neurological disorders.
| Federal Grant Title: | The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-NS-26-010 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.853 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | March 9th, 2026 |
| Original Application Deadline: | March 9th, 2026 |
| Posted Date: | February 6th, 2026 |
| Creation Date: | February 6th, 2026 |
| Archive Date: | May 8th, 2026 |
| Total Program Funding: | $1,950,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | February 6th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- [email protected]
[email protected]
[email protected] - Similar Government Grants
- • Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 C...
- • Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG...
- • Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical ...
- • Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neur...
- • Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Al...
- • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
- • NINDS Institutional Center Core Grants to Support Neuroscience Research
- • Career Development Award to Promote Diversity in Neuroscience Research
- More Grants from the National Institutes of Health
- • The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Lab...
- • The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations ...
- • NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
- • Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Data Processing...
- • NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
